800
Views
16
CrossRef citations to date
0
Altmetric
Drug Profile

New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine

, , , , , , , , , , , , , & show all
Pages 483-495 | Received 26 Dec 2015, Accepted 30 Mar 2016, Published online: 18 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rohini Bose, Syed Usman Hamdani, Fareed Aslam Minhas & Keira Joann Herr. (2022) A comparison of real-world effectiveness of vortioxetine along the treatment algorithm for major depressive disorder. Current Medical Research and Opinion 38:5, pages 661-671.
Read now
Janne Kaergaard Mortensen & Grethe Andersen. (2021) Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance. Expert Opinion on Pharmacotherapy 22:9, pages 1157-1166.
Read now

Articles from other publishers (14)

Xue Chen, Jing Li, Lisa Yu, Francesca Maule, Limei Chang, Jonathan A. Gallant, David J. Press, Sheetal A. Raithatha, Jillian M. Hagel & Peter J. Facchini. (2023) A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines. Journal of Biological Chemistry 299:10, pages 105231.
Crossref
Jan Juřica. (2021) Tolerability of antidepressants, their multimodal effects and mechanisms of their side effects. Psychiatrie pro praxi 22:3, pages 150-156.
Crossref
Gustavo R. Villas-Boas, Stefânia N. Lavorato, Marina M. Paes, Pablinny M. G. de Carvalho, Vanessa C. Rescia, Mila S. Cunha, Manoel F. de Magalhães-Filho, Luis F. Ponsoni, Adryano Augustto Valladao de Carvalho, Roseli B. de Lacerda, Lais da S. Leite, Matheus da S. Tavares-Henriques, Luiz A. F. Lopes, Luiz G. R. Oliveira, Saulo E. Silva-Filho, Ana P. S. da Silveira, Roberto K. N. Cuman, Francielli M. de S. Silva-Comar, Jurandir F. Comar, Luana do A. Brasileiro, Jussileide N. dos Santos, William R. de Freitas, Katyuscya V. Leão, Jonatas G. da Silva, Raphael C. Klein, Mary H. F. Klein, Bruno H. da S. Ramos, Cristiane K. C. Fernandes, Dayane G. de L. Ribas & Silvia A. Oesterreich. (2021) Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence. Pharmaceuticals 14:2, pages 148.
Crossref
Weiwei Xue, Tingting Fu, Guoxun Zheng, Gao Tu, Yang Zhang, Fengyuan Yang, Lin Tao, Lixia Yao & Feng Zhu. (2020) Recent Advances and Challenges of the Drugs Acting on Monoamine Transporters. Current Medicinal Chemistry 27:23, pages 3830-3876.
Crossref
Domenico De Berardis, Michele Fornaro, Annalisa Anastasia, Federica Vellante, Luigi Olivieri, Gabriella Rapini, Nicola Serroni, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Carmine Tomasetti, Antonio Ventriglio, Massimiliano Bustini, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Felice Iasevoli, Giovanni Martinotti & Massimo Di Giannantonio. (2020) Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study. Brazilian Journal of Psychiatry 42:3, pages 317-321.
Crossref
Sebastian A. Alvano & Luis M. Zieher. (2020) An updated classification of antidepressants: A proposal to simplify treatment. Personalized Medicine in Psychiatry 19-20, pages 100042.
Crossref
Hatylas Azevedo, Marcos Ferreira, Renata Watanabe Costa, Valter Russo, Elisa Russo, Alessandra Mascarello & Cristiano Ruch Werneck Guimarães. (2019) Preclinical characterization of ACH-000029, a novel anxiolytic compound acting on serotonergic and alpha-adrenergic receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 95, pages 109707.
Crossref
Benedicte Ballanger, Kevin G. Bath & Nathalie Mandairon. (2019) Odorants: a tool to provide nonpharmacological intervention to reduce anxiety during normal and pathological aging. Neurobiology of Aging 82, pages 18-29.
Crossref
Felix-Martin Werner & Rafael Coveñas. (2019) Therapeutic Effect of Novel Antidepressant Drugs Acting at Specific Receptors of Neurotransmitters and Neuropeptides. Current Pharmaceutical Design 25:4, pages 388-395.
Crossref
Carmine Tomasetti, Chiara Montemitro, Annastasia L.C. Fiengo, Cristina Santone, Laura Orsolini, Alessandro Valchera, Alessandro Carano, Maurizio Pompili, Gianluca Serafini, Giampaolo Perna, Federica Vellante, Giovanni Martinotti, Massimo D. Giannantonio, Yong-Ku Kim, Marco D. Nicola, Antonello Bellomo, Antonio Ventriglio, Michele Fornaro & Domenico D. Berardis. (2019) Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System. Current Pharmaceutical Design 25:4, pages 381-387.
Crossref
Anish Shah & Joanne Northcutt. (2018) An open-label, flexible dose adaptive study evaluating the efficacy of vortioxetine in subjects with panic disorder. Annals of General Psychiatry 17:1.
Crossref
Sidney H. Kennedy, Jean-Marie Grouin, Stéphanie Cadour, Véronique Robert & Françoise Picarel-Blanchot. (2018) Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder. Human Psychopharmacology: Clinical and Experimental 33:1, pages e2646.
Crossref
Domenico De Berardis, Luigi Olivieri, Francesco Nappi, Gabriella Rapini, Federica Vellante, Ilaria Matarazzo, Nicola Serroni & Massimo Di Giannantonio. (2017) Vortioxetine and Aripiprazole Combination in Treatment-Resistant Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 37:6, pages 732-734.
Crossref
Marina Dyskant Mochcovitch, Rafael Christophe da Rocha Freire, Rafael Ferreira Garcia & Antonio Egidio Nardi. (2017) Can Long-Term Pharmacotherapy Prevent Relapses in Generalized Anxiety Disorder? A Systematic Review. Clinical Drug Investigation 37:8, pages 737-743.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.